These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 3859217)
1. Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer. Wade JC; Standiford HC; Drusano GL; Johnson DE; Moody MR; Bustamante CI; Joshi JH; deJongh C; Schimpff SC Am J Med; 1985 Jun; 78(6A):62-72. PubMed ID: 3859217 [TBL] [Abstract][Full Text] [Related]
2. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study. Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044 [TBL] [Abstract][Full Text] [Related]
3. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients. Wade JC; Johnson DE; Bustamante CI Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273 [TBL] [Abstract][Full Text] [Related]
4. Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis. Chadwick EG; Shulman ST; Yogev R J Infect Dis; 1986 Oct; 154(4):670-5. PubMed ID: 3528320 [TBL] [Abstract][Full Text] [Related]
5. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Rolston KV; Berkey P; Bodey GP; Anaissie EJ; Khardori NM; Joshi JH; Keating MJ; Holmes FA; Cabanillas FF; Elting L Arch Intern Med; 1992 Feb; 152(2):283-91. PubMed ID: 1739355 [TBL] [Abstract][Full Text] [Related]
7. Empiric antibiotic therapy for granulocytopenic cancer patients. Schimpff SC Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270 [TBL] [Abstract][Full Text] [Related]
8. In vitro models for the study of combination antibiotic therapy in neutropenic patients. Zinner SH; Dudley M; Blaser J Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526 [TBL] [Abstract][Full Text] [Related]
9. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269 [TBL] [Abstract][Full Text] [Related]
10. [Monotherapy with meropenem in febrile granulocytopenic patients]. Sanz MA; Jarque I; Larrea L Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():69-72. PubMed ID: 9410073 [TBL] [Abstract][Full Text] [Related]
11. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Cometta A; Calandra T; Gaya H; Zinner SH; de Bock R; Del Favero A; Bucaneve G; Crokaert F; Kern WV; Klastersky J; Langenaeken I; Micozzi A; Padmos A; Paesmans M; Viscoli C; Glauser MP Antimicrob Agents Chemother; 1996 May; 40(5):1108-15. PubMed ID: 8723449 [TBL] [Abstract][Full Text] [Related]
12. Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone. Winston DJ; Ho WG; Bruckner DA; Champlin RE Ann Intern Med; 1991 Dec; 115(11):849-59. PubMed ID: 1952471 [TBL] [Abstract][Full Text] [Related]
13. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin. De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981 [TBL] [Abstract][Full Text] [Related]
14. Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients. Mortimer J; Miller S; Black D; Kwok K; Kirby WM Am J Med; 1988 Jul; 85(1A):17-20. PubMed ID: 3400679 [TBL] [Abstract][Full Text] [Related]
15. Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs. monotherapy. Wade JC Rev Infect Dis; 1989; 11 Suppl 7():S1572-81. PubMed ID: 2690295 [TBL] [Abstract][Full Text] [Related]
17. Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies. Vandercam B; Ezzeddine H; Agaliotis D; Gala JL; Gigi J; Wauters G; Michaux JL Acta Clin Belg; 1989; 44(2):99-109. PubMed ID: 2800889 [TBL] [Abstract][Full Text] [Related]
18. Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients. Aparicio J; Oltra A; Llorca C; Montalar J; Herranz C; Gómez-Codina J; Pastor M; Munárriz B Eur J Cancer; 1996 Sep; 32A(10):1739-43. PubMed ID: 8983283 [TBL] [Abstract][Full Text] [Related]
19. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside. Baruchel A; Hartmann O; Andremont A; Tancrède C J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190 [TBL] [Abstract][Full Text] [Related]
20. Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: an overview. Lieschke GJ; Bell D; Rawlinson W; Green MD; Sheridan W; Morstyn G; Stuart-Harris R; Kefford RF; Levi J; Sorrell T Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S37-42. PubMed ID: 2693108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]